Abstract

Objectives: The most promising therapy for patients with advanced ischemic-heart disease is coronary-artery bypass grafting (CABG). The mainly used graft-materials are autologous saphenous-veins. However, they are prone to occlude at high rates, causing infarctions and the necessity for high-risk redo-surgery. Recently, a Nitinol-based external vein support mesh (eSVS™) was developed and tested in animals. It revealed superb patency and long-term lack of intimal hyperplasia in supported grafts. We report the first in-the-human implantations in patients undergoing CABG.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call